Fitzpatrick successfully obtained a jury verdict of no invalidity and no inequitable conduct on behalf of its client Novartis Pharmaceutical against Teva Pharmaceuticals in a litigation involving the patent on the herpes drug famciclovir. The jury deliberated for 4 hours before announcing its verdict, November 18, 2009, in Federal District Court of New Jersey, Newark section, before District Judge Dennis M. Cavanaugh.

The Fitzpatrick team was led by partners Robert Baechtold, Nicholas Kallas and Simon Roberts, and co-counsel for Novartis was Cravath, Swaine & Moore.